Wellgistics Health Expands Agreement With Tollo Health To Provide GLP-1 Companion Muscle Loss Medical Food To Its Over 6.5K Independent Pharmacy Network, Physicians

Author: Benzinga Newsdesk | November 14, 2025 09:07am

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a leader in the integration of physical and technology healthcare infrastructure for prescription drugs, today announced that it has expanded its agreement with Tollo Health to offer the first GLP-1 companion muscle loss medical food to its 6,500+ independent pharmacy network (‘Pharmacy Network') and physicians. The product is a branded version of a proprietary formulation that has been widely studied in metabolic dysfunction, with patients presenting diabetes type 2, heart failure, and COPD. Wellgistics will be selling the medical food as an adjunct to GLP-1 therapies to help mitigate muscle loss during weight loss while on therapy and to mitigate weight after discontinuation.

Posted In: WGRX